{
    "items": [
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343613\" title=\"The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343613/@@modal\" class=\"state-synced\">The Target UK Study: Real-World Evidence of Molecular Response to Tyrosine Kinase Inhibitors Supports European Leukemianet 2013 Recommendations for the Management of Chronic Myeloid Leukaemia</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Milojkovic D. et al, (2017), BLOOD, 130</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        <div class=\"altmetric-embed\" data-badge-popover=\"top\" data-badge-type=\"donut\" data-doi=\"10.1182/blood.V128.22.4271.4271\" data-hide-no-mentions=\"true\" data-link-target=\"_blank\"></div>\n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343617\" title=\"Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343617/@@modal\" class=\"state-synced\">Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mesa RA. et al, (2016), BLOOD, 128</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        <div class=\"altmetric-embed\" data-badge-popover=\"top\" data-badge-type=\"donut\" data-doi=\"10.1182/blood.V128.22.479.479\" data-hide-no-mentions=\"true\" data-link-target=\"_blank\"></div>\n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343619\" title=\"Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343619/@@modal\" class=\"state-synced\">Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mascarenhas JO. et al, (2016), BLOOD, 128</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        <div class=\"altmetric-embed\" data-badge-popover=\"top\" data-badge-type=\"donut\" data-doi=\"10.1200/JCO.2016.34.15_suppl.7066\" data-hide-no-mentions=\"true\" data-link-target=\"_blank\"></div>\n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343620\" title=\"Outcomes in patients with myelofibrosis and RBC-transfusion dependence in the phase III PERSIST-1 study of pacritinib vs. best available therapy.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343620/@@modal\" class=\"state-synced\">Outcomes in patients with myelofibrosis and RBC-transfusion dependence in the phase III PERSIST-1 study of pacritinib vs. best available therapy.</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Harrison CN. et al, (2016), JOURNAL OF CLINICAL ONCOLOGY, 34</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        <div class=\"altmetric-embed\" data-badge-popover=\"top\" data-badge-type=\"donut\" data-doi=\"10.1200/JCO.2016.34.15_suppl.7065\" data-hide-no-mentions=\"true\" data-link-target=\"_blank\"></div>\n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343622\" title=\"Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343622/@@modal\" class=\"state-synced\">Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial.</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mesa RA. et al, (2016), JOURNAL OF CLINICAL ONCOLOGY, 34</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        <div class=\"altmetric-embed\" data-badge-popover=\"top\" data-badge-type=\"donut\" data-doi=\"10.1200/JCO.2016.34.15_suppl.7011\" data-hide-no-mentions=\"true\" data-link-target=\"_blank\"></div>\n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343621\" title=\"Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343621/@@modal\" class=\"state-synced\">Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Outcomes in patients (pts) with baseline (BL) thrombocytopenia.</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Harrison CN. et al, (2016), JOURNAL OF CLINICAL ONCOLOGY, 34</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        <div class=\"altmetric-embed\" data-badge-popover=\"top\" data-badge-type=\"donut\" data-doi=\"10.1182/blood.V128.22.3131.3131\" data-hide-no-mentions=\"true\" data-link-target=\"_blank\"></div>\n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343618\" title=\"Relationship of JAK2V617F Allelic Burden (AB) to Demographics, Disease Characteristics, and Response to Therapy in Persist-1, a Randomized Phase III Study of Pacritinib (PAC) Versus Best Available Therapy (BAT) in Patients (pts) with Primary and Secondary Myelofibrosis (MF)\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343618/@@modal\" class=\"state-synced\">Relationship of JAK2V617F Allelic Burden (AB) to Demographics, Disease Characteristics, and Response to Therapy in Persist-1, a Randomized Phase III Study of Pacritinib (PAC) Versus Best Available Therapy (BAT) in Patients (pts) with Primary and Secondary Myelofibrosis (MF)</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Vannucchi AM. et al, (2016), BLOOD, 128</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343623\" title=\"Analysis of Outcomes By Patient Subgroups in Patients with Myelofibrosis Treated with Pacritinib Vs Best Available Therapy (BAT) in the Phase III Persist-1 Trial\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343623/@@modal\" class=\"state-synced\">Analysis of Outcomes By Patient Subgroups in Patients with Myelofibrosis Treated with Pacritinib Vs Best Available Therapy (BAT) in the Phase III Persist-1 Trial</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Vannucchi AM. et al, (2015), BLOOD, 126</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343624\" title=\"Assessment and Validation of the EQ-5D Among a Population of Myeloproliferative Neoplasm Patients\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343624/@@modal\" class=\"state-synced\">Assessment and Validation of the EQ-5D Among a Population of Myeloproliferative Neoplasm Patients</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Scherber RM. et al, (2015), BLOOD, 126</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343626\" title=\"Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343626/@@modal\" class=\"state-synced\">Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mesa RA. et al, (2015), JOURNAL OF CLINICAL ONCOLOGY, 33</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343625\" title=\"Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF)\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343625/@@modal\" class=\"state-synced\">Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF)</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mesa RA. et al, (2015), JOURNAL OF CLINICAL ONCOLOGY, 33</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343627\" title=\"Response To Ruxolitinib In Patients With Intermediate-1, Intermediate-2 and High-Risk Myelofibrosis: Interim Results Of The UK Robust Trial\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343627/@@modal\" class=\"state-synced\">Response To Ruxolitinib In Patients With Intermediate-1, Intermediate-2 and High-Risk Myelofibrosis: Interim Results Of The UK Robust Trial</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Harrison CN. et al, (2013), BLOOD, 122</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343628\" title=\"FLT3 ITD and TKD Mutations Differ in Their Functional Consequence in Both Cell Line Models and Primary Hematopoietic Cells.\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343628/@@modal\" class=\"state-synced\">FLT3 ITD and TKD Mutations Differ in Their Functional Consequence in Both Cell Line Models and Primary Hematopoietic Cells.</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mead AJ. et al, (2008), BLOOD, 112, 1297 - 1297</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n", 
        "\n\n    <div class=\"listing-item listing-item-publication\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/PublicationVolume\">\n\n        <div class=\"row\">\n\n            \n\n            <div class=\"col-xs-12\">\n                            \n                \n                    <div class=\"pull-right\">\n                        \n                    </div>\n                \n            \n                <h2 class=\"media-heading\">\n                    <a href=\"https://www.paediatrics.ox.ac.uk/publications/1343629\" title=\"Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation\" data-toggle=\"modal\" data-target=\"#modal\" itemprop=\"name\" data-href=\"https://www.paediatrics.ox.ac.uk/publications/1343629/@@modal\" class=\"state-synced\">Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation</a>\n                </h2>\n  \n                \n                    \n                \n\n                \n                \n                        \n                    <p itemprop=\"description\">Mead AJ. et al, (2008), BLOOD, 112, 1035 - 1035</p>\n                \n                        \n                \n                    <p>\n                        \n                    </p>\n                \n                \n            </div>\n\n        </div>\n\n    </div>\n\n\n"
    ], 
    "more": "\n\n    \n\n", 
    "msg": ""
}